|
US2951540A
(en)
|
1956-11-05 |
1960-09-06 |
Gen Motors Corp |
Propeller brake
|
|
US3709898A
(en)
|
1971-02-09 |
1973-01-09 |
Upjohn Co |
Process for the production of triazolobenzodiazepines and intermediates
|
|
US3681343A
(en)
|
1971-05-11 |
1972-08-01 |
Upjohn Co |
6-phenyl-s-triazolo{8 4,3-a{9 {8 1,4{9 {0 benzodiazepines
|
|
US3812259A
(en)
|
1971-08-09 |
1974-05-21 |
Upjohn Co |
Animal feed and process
|
|
CH622019A5
(en)
|
1975-10-23 |
1981-03-13 |
Upjohn Co |
Process for the preparation of aminotriazolobenzodiazepines
|
|
FR2329668A1
(fr)
|
1975-10-27 |
1977-05-27 |
Upjohn Co |
Procede de preparation d'aminotriazolobenzodiazepines
|
|
EP0087850A1
(en)
|
1982-01-04 |
1983-09-07 |
The Upjohn Company |
Benzodiazepines for anti-hypertensive use
|
|
DE3435973A1
(de)
|
1984-10-01 |
1986-04-10 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
|
|
DE3724164A1
(de)
|
1986-07-25 |
1988-01-28 |
Boehringer Ingelheim Kg |
Neue 1,4-benzodiazepine, ihre herstellung und verwendung
|
|
EP0315698B1
(en)
|
1987-05-28 |
1993-03-03 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thieno(triazolo)diazepine compounds and medicinal application of the same
|
|
JPH0676326B2
(ja)
|
1988-05-24 |
1994-09-28 |
吉富製薬株式会社 |
循環器系疾患治療薬
|
|
EP0368175A1
(de)
|
1988-11-06 |
1990-05-16 |
Boehringer Ingelheim Kg |
3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
|
|
EP0387613A1
(de)
|
1989-03-03 |
1990-09-19 |
Boehringer Ingelheim Kg |
Neue Thienodiazepine
|
|
EP0407955A1
(de)
|
1989-07-12 |
1991-01-16 |
Boehringer Ingelheim Kg |
Neue Hetrazepine mit PAF-antagonistischer Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE4010528A1
(de)
|
1990-04-02 |
1991-10-17 |
Boehringer Ingelheim Kg |
Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
|
|
KR100255493B1
(ko)
|
1991-10-11 |
2000-08-01 |
가마쿠라 아키오 |
골조송증 치료제
|
|
EP0661284A1
(en)
|
1992-09-18 |
1995-07-05 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienodiazepine compound and medicinal use thereof
|
|
WO1994022872A1
(en)
|
1993-03-30 |
1994-10-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Cell adhesion inhibitor and thienotriazolodiazepine compound
|
|
WO1995032963A1
(fr)
|
1994-06-01 |
1995-12-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienylazole et compose de thienotriazolodiazepine
|
|
TR199700587T1
(xx)
|
1995-01-06 |
1998-02-21 |
F. Hoffmann-La Roche Ag |
Hidroksimetil-imidazodiazepin ve bunlar�n esterleri.
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
PT832066E
(pt)
*
|
1995-06-06 |
2001-12-28 |
Pfizer |
N-substituido-(indole-2-carbonil)-amidas e derivados como inibidores de glicogenio-fosforilase
|
|
DE69523182T2
(de)
*
|
1995-06-06 |
2002-02-07 |
Pfizer |
Substituierte n-(indol-2-carbonyl)-glycinamide und derivate als glycogen phosphorylase inhibitoren
|
|
WO1997009048A1
(en)
|
1995-09-09 |
1997-03-13 |
F. Hoffmann-La Roche Ag |
Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
EP0934940A1
(en)
|
1996-06-12 |
1999-08-11 |
Japan Tobacco Inc. |
Cytokine production inhibitors, triazepine compounds, and intermediates thereof
|
|
US5693641A
(en)
|
1996-08-16 |
1997-12-02 |
Berlex Laboratories Inc. |
Bicyclic pyrimidine derivatives and their use as anti-coagulants
|
|
WO1998011111A1
(fr)
|
1996-09-13 |
1998-03-19 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Composes de thienotriazolodiazepine et leurs utilisations a des fins medicinales
|
|
US6444664B1
(en)
|
1997-04-18 |
2002-09-03 |
Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) |
Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
|
|
JPH11228576A
(ja)
|
1997-12-10 |
1999-08-24 |
Japan Tobacco Inc |
アポトーシス抑制剤
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
FR2779652B1
(fr)
|
1998-06-15 |
2001-06-08 |
Sod Conseils Rech Applic |
Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
|
|
KR20000016732A
(en)
|
1998-12-12 |
2000-03-25 |
Japan Tobacco Inc |
Cytokine production inhibitors, triazepine compounds, and intermediates thereof
|
|
BR0010524A
(pt)
|
1999-05-14 |
2002-05-28 |
Imclone Systems Inc |
Tratamento de tumores humanos refratários com antagonistas de receptor de fator de crescimento epidérmico
|
|
US6312215B1
(en)
|
2000-02-15 |
2001-11-06 |
United Technologies Corporation |
Turbine engine windmilling brake
|
|
US7589167B2
(en)
|
2000-02-22 |
2009-09-15 |
J. David Gladstone Institutes |
ZA loops of bromodomains
|
|
AU2001264303A1
(en)
|
2000-06-16 |
2001-12-24 |
Mitsubishi Pharma Corporation |
Compositions controlling release ph range and/or speed
|
|
US6552037B2
(en)
|
2000-06-30 |
2003-04-22 |
Neurogen Corporation |
2-Substituted imidazo[1,2-A]pyridine derivatives
|
|
US20060142257A1
(en)
|
2001-01-19 |
2006-06-29 |
Eberhard Nieschlag |
Male contraceptive formulation comprising norethisterone
|
|
US6979682B2
(en)
|
2001-02-23 |
2005-12-27 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Platelet-activating factor antagonist inhibition of angiogenesis and tumor growth induced by basic fibroblast
|
|
US20030216758A1
(en)
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
PL378116A1
(pl)
|
2003-02-27 |
2006-03-06 |
Abbott Laboratories |
Heterocykliczne inhibitory kinazy
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
EP1656155A2
(en)
|
2003-06-02 |
2006-05-17 |
Ohio University |
Use of genes differentially expressed during aging of liver for treatment and diagnosis
|
|
WO2005002526A2
(en)
|
2003-07-01 |
2005-01-13 |
President And Fellows Of Harvard College |
Method and compositions for treatment of viral infections
|
|
WO2005026130A1
(en)
|
2003-09-18 |
2005-03-24 |
Novartis Ag |
2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
|
|
EP1528056A1
(en)
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
|
US20060035903A1
(en)
|
2004-08-14 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Storage stable perfusion solution for dihydropteridinones
|
|
US7759485B2
(en)
|
2004-08-14 |
2010-07-20 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of dihydropteridinones
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
|
CN1759834B
(zh)
|
2004-09-17 |
2010-06-23 |
中国医学科学院医药生物技术研究所 |
黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
|
|
US8624027B2
(en)
|
2005-05-12 |
2014-01-07 |
Abbvie Inc. |
Combination therapy for treating cancer and diagnostic assays for use therein
|
|
TWI447120B
(zh)
|
2005-05-30 |
2014-08-01 |
Mitsubishi Tanabe Pharma Corp |
噻吩并三唑并苯二氮呯化合物、其醫藥上之用途
|
|
WO2007014838A1
(en)
|
2005-08-03 |
2007-02-08 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones in the treatment of respiratory diseases
|
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
PL1951684T3
(pl)
|
2005-11-01 |
2017-03-31 |
Targegen, Inc. |
Biarylowe meta-pirymidynowe inhibitory kinaz
|
|
AR058505A1
(es)
|
2005-11-04 |
2008-02-06 |
Wyeth Corp |
Combinaciones antineoplasicas de temsirolimus y malato de sunitinib
|
|
SI1962830T1
(sl)
|
2005-12-23 |
2013-07-31 |
Glaxosmithkline Llc |
Azaindolni inhibitorji kinaz Aurora
|
|
JP4913157B2
(ja)
|
2006-01-17 |
2012-04-11 |
エフ．ホフマン−ラ ロシュ アーゲー |
ＧＡＢＡレセプター経由でのアルツハイマー病の処置に有用なアリール−イソオキサゾール−４−イル−イミダゾ［１，２−ａ］ピリジン誘導体
|
|
ATE479434T1
(de)
|
2006-02-14 |
2010-09-15 |
Vertex Pharma |
Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
|
|
US20070218135A1
(en)
|
2006-03-14 |
2007-09-20 |
Glenmark Pharmaceuticals Limited |
Sustained release matrix pharmaceutical composition
|
|
WO2007131005A2
(en)
|
2006-05-03 |
2007-11-15 |
Novartis Ag |
Use of organic compounds
|
|
US7621117B2
(en)
|
2006-06-19 |
2009-11-24 |
Pratt & Whitney Canada Corp. |
Apparatus and method for controlling engine windmilling
|
|
ES2627352T3
(es)
|
2006-10-19 |
2017-07-27 |
Signal Pharmaceuticals, Llc |
Compuestos heteroarilo, sus composiciones y su uso como inhibidores de proteínas quinasas
|
|
US8338464B2
(en)
|
2006-11-30 |
2012-12-25 |
Albert Einstein College Of Medicine Of Yeshiva University |
Small molecule inhibitors of BCL6
|
|
BRPI0722082A8
(pt)
|
2006-12-26 |
2018-03-13 |
Lantheus Medical Imaging Inc |
ligantes para imagiologia da inervação cardíaca
|
|
JP2008156311A
(ja)
|
2006-12-26 |
2008-07-10 |
Institute Of Physical & Chemical Research |
Ｂｒｄ２ブロモドメイン結合剤
|
|
WO2008137081A1
(en)
|
2007-05-02 |
2008-11-13 |
The Trustees Of Columbia University In The City Of New York |
Substituted ( 5, 6 ) -dihydronaphraalenyl compounds as reversible male contraceptives
|
|
KR20080107050A
(ko)
|
2007-06-05 |
2008-12-10 |
울산대학교 산학협력단 |
항-ｃｄ１３７ 단일클론 항체를 포함하는 만성이식편대숙주 질환의 예방 또는 치료용 약학적 조성물
|
|
US20110028405A1
(en)
|
2007-12-20 |
2011-02-03 |
Richard John Harrison |
Sulfamides as zap-70 inhibitors
|
|
WO2009084693A1
(ja)
|
2007-12-28 |
2009-07-09 |
Mitsubishi Tanabe Pharma Corporation |
抗癌剤
|
|
CN101910914B
(zh)
*
|
2007-12-28 |
2013-03-27 |
日本电信电话株式会社 |
变焦透镜
|
|
US20110098288A1
(en)
|
2008-03-11 |
2011-04-28 |
Jeremy Major |
Sulfonamides as zap-70 inhibitors
|
|
WO2010015340A1
(en)
|
2008-08-06 |
2010-02-11 |
Bayer Schering Pharma Aktiengesellschaft |
Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
|
|
ES2448567T3
(es)
|
2008-10-30 |
2014-03-14 |
Circomed Llc |
Derivados de la tienotriazoldiazepina activos en apo A
|
|
EP3828185A3
(en)
|
2009-01-06 |
2021-09-01 |
Dana Farber Cancer Institute, Inc. |
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
|
|
SG172958A1
(en)
|
2009-01-23 |
2011-08-29 |
Takeda Pharmaceutical |
Poly (adp-ribose) polymerase (parp) inhibitors
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919426D0
(en)
*
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2496582B1
(en)
|
2009-11-05 |
2016-01-27 |
GlaxoSmithKline LLC |
Benzodiazepine bromodomain inhibitor
|
|
KR101424989B1
(ko)
|
2009-11-05 |
2014-07-31 |
글락소스미스클라인 엘엘씨 |
벤조디아제핀 브로모도메인 억제제
|
|
US8862173B2
(en)
|
2009-12-10 |
2014-10-14 |
Motorola Solutions, Inc. |
Method for selecting media for delivery to users at an incident
|
|
EP2536725B1
(en)
|
2010-02-17 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
Dihydropteridinones, method for production and use thereof
|
|
US9624870B2
(en)
|
2010-03-26 |
2017-04-18 |
Rolls-Royce North American Technologies, Inc. |
Adaptive fan system for a variable cycle turbofan engine
|
|
JP5935030B2
(ja)
|
2010-05-14 |
2016-06-15 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
白血病を治療するための組成物および方法
|
|
WO2011143651A1
(en)
*
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating metabolism
|
|
MX362384B
(es)
|
2010-05-14 |
2019-01-15 |
Dana Farber Cancer Inst Inc |
Composiciones y metodos para tratar neoplasias, enfermedades inflamatorias y otros trastornos.
|
|
CA2799381A1
(en)
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Male contraceptive compositions and methods of use
|
|
JP5715241B2
(ja)
|
2010-05-14 |
2015-05-07 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法
|
|
WO2011161031A1
(en)
|
2010-06-22 |
2011-12-29 |
Glaxosmithkline Llc |
Benzotriazolodiazepine compounds inhibitors of bromodomains
|
|
CA2805413A1
(en)
|
2010-06-25 |
2011-12-29 |
Shire Human Genetic Therapies, Inc. |
Methods and compositions for cns delivery of heparan n-sulfatase
|
|
US20120014979A1
(en)
|
2010-07-16 |
2012-01-19 |
Alexander Dent |
Use of bcl6 inhibitors for treating autoimmune diseases
|
|
TWI549955B
(zh)
|
2010-08-04 |
2016-09-21 |
達納 法柏癌症學院有限公司 |
治療腫瘤形成、發炎疾病及其他病症之組成物及方法
|
|
CN103228142A
(zh)
|
2010-09-28 |
2013-07-31 |
加利福尼亚大学董事会 |
治疗代谢综合征相关疾病的gaba激动剂和治疗或预防i型糖尿病的gaba组合
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
US20130004481A1
(en)
|
2011-01-12 |
2013-01-03 |
Boehringer Ingelheim International Gmbh |
Anticancer therapy
|
|
AU2012220620A1
(en)
|
2011-02-23 |
2013-10-03 |
Icahn School Of Medicine At Mount Sinai |
Inhibitors of bromodomains as modulators of gene expression
|
|
JP2014511389A
(ja)
|
2011-02-28 |
2014-05-15 |
エピザイム インコーポレイテッド |
置換６，５−縮合二環式ヘテロアリール化合物
|
|
WO2012119095A1
(en)
|
2011-03-02 |
2012-09-07 |
Board Of Regents, The University Of Texas System |
Fus1/tusc2 therapies
|
|
WO2013019710A1
(en)
|
2011-07-29 |
2013-02-07 |
The Children's Hospital Of Philadelphia |
Compositions and methods for the treatment of hiv
|
|
WO2013033268A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
FI20110279A0
(fi)
|
2011-08-29 |
2011-08-29 |
Outotec Oyj |
Menetelmä metallien talteenottamiseksi niitä sisältävästä materiaalista
|
|
WO2013033269A1
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
|
US10071129B2
(en)
|
2011-08-30 |
2018-09-11 |
Whitehead Institute For Biomedical Research Dana-Farber Cancer Institute, Inc. |
Method for identifying bromodomain inhibitors
|
|
DE102011082013A1
(de)
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
CN104203267A
(zh)
|
2012-02-17 |
2014-12-10 |
安迅生物制药公司 |
用于治疗流感和副流感患者的方法、化合物和组合物
|
|
US20150133434A1
(en)
|
2012-03-28 |
2015-05-14 |
The J. David Gladstone Institutes |
Compositions and Methods for Reactivating Latent Immunodeficiency Virus
|
|
US9763956B2
(en)
|
2012-06-19 |
2017-09-19 |
The Broad Institute, Inc. |
Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy
|
|
KR20150100613A
(ko)
|
2012-09-28 |
2015-09-02 |
온코에틱스 게엠베하 |
티에노트리아졸로디아제핀 화합물을 함유하는 약제학적 제제
|
|
WO2014071247A1
(en)
|
2012-11-02 |
2014-05-08 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1 -yl benzoic acid derivates useful as myc inhibitors
|
|
US20160009725A1
(en)
|
2013-02-22 |
2016-01-14 |
Bayer Pharma Aktiengesellschaft |
Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases
|
|
EP2958923A1
(de)
|
2013-02-22 |
2015-12-30 |
Bayer Pharma Aktiengesellschaft |
4-substituierte pyrrolo- und pyrazolo-diazepine
|
|
EP2961411A4
(en)
|
2013-02-28 |
2016-11-23 |
Univ Washington |
METHOD FOR TREATING INFECTIONS WITH HUMAN CYTOMAL GALOVIRUS AND DISEASES WITH BROMDOMAIN DISEASES
|
|
US9714946B2
(en)
|
2013-03-14 |
2017-07-25 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
MX2015012428A
(es)
|
2013-03-15 |
2016-01-12 |
Genentech Inc |
Tratamiento contra enfermedades mediadas th2 por inhibicion de bromodominios.
|
|
WO2014193951A1
(en)
|
2013-05-28 |
2014-12-04 |
Dana-Farber Cancer Institute, Inc. |
Bet inhibition therapy for heart disease
|
|
DE102013106353B4
(de)
|
2013-06-18 |
2018-06-28 |
Tdk Corporation |
Verfahren zum Aufbringen einer strukturierten Beschichtung auf ein Bauelement
|
|
RU2016105108A
(ru)
|
2013-07-25 |
2017-08-30 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Ингибиторы факторов транскрипции и их применение
|
|
WO2015018522A1
(en)
|
2013-08-06 |
2015-02-12 |
Oncoethix Sa |
Bet-bromodomain inhibitor shows synergism with several anti-cancer agents in pre-clinical models of diffuse large b-cell lymphoma (dlbcl)
|
|
EP3030242A1
(en)
|
2013-08-06 |
2016-06-15 |
Oncoethix GmbH |
Method of treating diffuse large b-cell lymphoma (dlbcl) using a bet-bromodomain inhibitor
|
|
WO2015023938A1
(en)
|
2013-08-16 |
2015-02-19 |
Rana Therapeutics, Inc. |
Epigenetic regulators of frataxin
|
|
US8988212B2
(en)
|
2013-08-22 |
2015-03-24 |
GM Global Technology Operations LLC |
Electric vehicle pedestrian warning system
|
|
AU2014323526B2
(en)
|
2013-09-19 |
2020-07-23 |
Dana-Farber Cancer Institute, Inc. |
Methods of BH3 profiling
|
|
BR112016007891A2
(pt)
|
2013-10-11 |
2017-12-05 |
Constellation Pharmaceuticals Inc |
uso de inibidores de bromodomínio cbp/ep300 para imunoterapia do câncer
|
|
CN105849110B
(zh)
|
2013-11-08 |
2019-08-02 |
达纳-法伯癌症研究所有限公司 |
使用溴结构域和额外终端(bet)蛋白抑制剂的用于癌症的组合疗法
|
|
WO2015081284A1
(en)
|
2013-11-26 |
2015-06-04 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
|
JP2017504650A
(ja)
|
2014-01-31 |
2017-02-09 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
ジアゼパン誘導体およびその使用
|
|
WO2015117053A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Diaminopyrimidine benzenesulfone derivatives and uses thereof
|
|
JP2017504651A
(ja)
|
2014-01-31 |
2017-02-09 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
ジアゼパン誘導体の使用
|
|
CA2940472A1
(en)
|
2014-02-28 |
2015-09-03 |
Tensha Therapeutics, Inc. |
Treatment of conditions associated with hyperinsulinaemia
|
|
SG11201703414VA
(en)
|
2014-10-27 |
2017-05-30 |
Tensha Therapeutics Inc |
Bromodomain inhibitors
|
|
SG11201704089UA
(en)
|
2014-12-05 |
2017-06-29 |
H Lee Moffitt Cancer Ct & Res |
Bromodomain inhibitor as adjuvant in cancer immunotherapy
|
|
EP3314005A1
(en)
|
2015-06-26 |
2018-05-02 |
Tensha Therapeutics, Inc. |
Treatment of nut midline carcinoma
|
|
WO2017059319A2
(en)
|
2015-10-02 |
2017-04-06 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of bromodomain inhibitors and checkpoint blockade
|
